Literature DB >> 29322330

Answering letter to remark of Dr's Frank and Fitzgerald.

Günther Krumpl1.   

Abstract

Year:  2018        PMID： 29322330     DOI： 10.1007/s00228-017-2409-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  21 in total

1.  The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.

Authors:  Yutaka Oda; Kiyonobu Nishikawa; Ichiro Hase; Akira Asada
Journal:  Anesth Analg       Date:  2005-03       Impact factor: 5.108

2.  Bolus administration of esmolol for controlling the haemodynamic response to tracheal intubation: the Canadian Multicentre Trial.

Authors:  D R Miller; R J Martineau; J E Wynands; J Hill
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

3.  Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.

Authors:  Jie Xiao; Ping He; Qiaoqun Zou; Yanhua Zhao; Zhanggang Xue; Xiaoming Deng; Shitong Li; Qunlian Guo; Guocai Tao; Tiande Yang; Zhixun Lang; Jia He; Xiangrui Wang
Journal:  J Clin Anesth       Date:  2014-11-28       Impact factor: 9.452

4.  The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery.

Authors:  T N Harwood; J Butterworth; R C Prielipp; R L Royster; K Hansen; G Plonk; R Dean
Journal:  J Cardiothorac Vasc Anesth       Date:  1999-10       Impact factor: 2.628

5.  Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol.

Authors:  A Sugiyama; A Takahara; K Hashimoto
Journal:  J Cardiovasc Pharmacol       Date:  1999-07       Impact factor: 3.105

6.  Comparative effects of ultra-short-acting beta1-blockers on voltage-gated tetrodotoxin-resistant Na+ channels in rat sensory neurons.

Authors:  Shigeaki Tanahashi; Hiroki Iida; Shuji Dohi; Akiyoshi Oda; Yoko Osawa; Shinobu Yamaguchi
Journal:  Eur J Anaesthesiol       Date:  2009-03       Impact factor: 4.330

7.  Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.

Authors:  S B Felix; V Stangl; A Kieback; W Doerffel; A Staudt; K D Wernecke; G Baumann; K Stangl
Journal:  J Cardiovasc Pharmacol       Date:  2001-11       Impact factor: 3.105

8.  Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).

Authors:  Ryozo Nagai; Koichiro Kinugawa; Hiroshi Inoue; Hirotsugu Atarashi; Yoshihiko Seino; Takeshi Yamashita; Wataru Shimizu; Takeshi Aiba; Masafumi Kitakaze; Atsuhiro Sakamoto; Takanori Ikeda; Yasushi Imai; Takashi Daimon; Katsuhiro Fujino; Tetsuji Nagano; Tatsuaki Okamura; Masatsugu Hori
Journal:  Circ J       Date:  2013-03-15       Impact factor: 2.993

9.  Cardiovascular effects of esmolol in anesthetized humans.

Authors:  P G Menkhaus; J G Reves; I Kissin; J M Alvis; A V Govier; P N Samuelson; W A Lell; C E Henling; E Bradley
Journal:  Anesth Analg       Date:  1985-03       Impact factor: 5.108

10.  Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Seong-Wook Jeong; Jun-Ichi Satoh; Akiyoshi Namiki
Journal:  Heart Lung       Date:  2008-09-11       Impact factor: 2.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.